Valdemarsson S, Hedner P, Nilsson-Ehle P
Scand J Clin Lab Invest. 1984 May;44(3):183-9. doi: 10.3109/00365518409083794.
The activities of hepatic lipase and of lipoprotein lipase, the elimination rate of exogenous triglyceride and the cholesterol esterification rate were determined and related to plasma lipoprotein concentrations in 16 patients before and after treatment for hyperthyroidism. The activity of hepatic lipase was significantly higher (65%) before than after treatment, while the activity of lipoprotein lipase and the elimination rate of exogenous triglyceride remained unchanged. The endogenous cholesterol esterifying ability decreased after treatment, whereas no change occurred in the fractional cholesterol esterification rate measured with normal plasma as substrate. The concentrations of LDL-cholesterol and HDL-cholesterol increased significantly after treatment. The decrease in hepatic lipase activities was correlated to the decrease in S-T3 concentrations (r = 0.77, P less than 0.001) and to the increase in HDL-cholesterol concentrations (r = 0.51, P less than 0.05). The activities of lipoprotein lipase were positively correlated to the concentrations of HDL-cholesterol both before (r = 0.54, P less than 0.05) and after (r = 0.59, P less than 0.05) treatment. These results support the view that hepatic lipase and lipoprotein lipase are both important determinants of plasma HDL concentrations and suggest that an increased hepatic lipase activity contributes to the lower HDL levels in hyperthyroid patients.
测定了16例甲状腺功能亢进患者治疗前后肝脂酶和脂蛋白脂酶的活性、外源性甘油三酯的清除率以及胆固醇酯化率,并将其与血浆脂蛋白浓度进行关联。治疗前肝脂酶活性显著高于治疗后(高65%),而脂蛋白脂酶活性和外源性甘油三酯的清除率保持不变。治疗后内源性胆固醇酯化能力下降,而以正常血浆为底物测得的胆固醇酯化率分数无变化。治疗后低密度脂蛋白胆固醇和高密度脂蛋白胆固醇浓度显著升高。肝脂酶活性的降低与血清三碘甲状腺原氨酸(S-T3)浓度的降低相关(r = 0.77,P < 0.001)以及与高密度脂蛋白胆固醇浓度的升高相关(r = 0.51,P < 0.05)。脂蛋白脂酶活性在治疗前(r = 0.54,P < 0.05)和治疗后(r = 0.59,P < 0.05)均与高密度脂蛋白胆固醇浓度呈正相关。这些结果支持以下观点,即肝脂酶和脂蛋白脂酶都是血浆高密度脂蛋白浓度的重要决定因素,并表明肝脂酶活性增加导致甲状腺功能亢进患者高密度脂蛋白水平降低。